Dr Reddy’s Laboratories Ltd. denied plans to implement a 25% workforce price discount by means of an change submitting on posted on NSE.
The pharmaceutical producer deemed the information of its plans to cut back workforce prices by 25% by way of main layoff initiatives, to be “factually incorrect”.
Saying that they “categorically deny” the declare which was first printed in Enterprise Customary’s information article ‘DRL Trims Workforce Prices By 25% Amid Revlimid-Linked Margin Pressure’.
“On this regard, please observe that the corporate doesn’t touch upon market speculations and there’s at present no such occasion or data which requires a disclosure,” the agency stated in its change submitting.